-
-
-
-
-
-
-
Akcea and Ionis Announce Approval of TEGSEDI⢠(inotersen) in the European Union
-
-
-
-
-
-
-
Akcea Reports Financial Results and Highlights for First Quarter 2018
-
-
-
-
-
-
-
Akcea Therapeutics (AKCA), Ionis (IONS) Announce Acceptance of Marketing Applications in U.S., EU and Canada for Volanesorsen for Treatment of FCS
-
15,420 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

